Gufic BioSciences Ltd

NSE: GUFICBIO · BSE: 509079 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹424.00
Market cap: ₹4,252 Cr
Revenue (annual): ₹944.0 Cr
Net profit (annual): ₹64.21 Cr
P/E (TTM): 57.9×Sector 47.4×
Promoter holding: 72.50%+0.00% QoQ
FII holding: 0.47%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 5 Financial Results 4 Acquisition 4 Other Announcement 3 Merger & Restructuring 3 Management Change 2 Legal & Regulatory 2 Board Meeting Outcome 2 Board Meeting Date 2 Annual General Meeting 2 Dividend 1 Credit Rating 1 Business Update 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

24 Sep 2026 15:25 IST BSE

Legal & Regulatory

Gufic BioSciences Legal & Regulatory

NSE rejected Gufic Biosciences' waiver application regarding a ₹1.72 lakh penalty for Regulation 17(1A) non-compliance. The company will pay the fine by October 03, 2026.

Value: ₹0.02 Cr

Read the filing ↗

3 Apr 2026 19:13 IST BSE

Legal & Regulatory

Gufic BioSciences Legal & Regulatory

Gufic Biosciences received an income tax order reducing a prior demand to Rs. 11.76 Lakhs, but imposing a penalty of Rs. 23.52 Lakhs (0.24 Cr) for under-reported income. The company intends to appeal the decision before the Commissioner of Income Tax (Appeals) based on tax consultant advice.

Value: ₹0.24 Cr

Read the filing ↗